Assoc. Prof. Esra Nur Ademoğlu Dilekçi is a specialist in endocrinology and metabolic diseases with clinical and academic experience. She completed her endocrinology and metabolic diseases training at Ankara Training and Research Hospital in 2012. Currently affiliated with Acıbadem Health Group since 2023, she provides care for patients with hormonal and metabolic disorders, including diabetes, thyroid disease, and obesity. She is an active member of professional societies, including the European Society of Endocrinology (ESE), the Turkish Society of Endocrinology and Metabolic Diseases, and the Turkish Obesity Research Association, reflecting her commitment to ongoing professional development and contributions to the field.
Education
- 2012 Ankara Training and Research Hospital Endocrinology and Metabolic Diseases
- 2004 Ankara Numune Training and Research Hospital Internal Medicine
- 1999 Gazi University Faculty of Medicine
Experience
- 2023 Acibadem Health Group
- 2021 – 2023 Medicana Health Group-Kadıköy Hospital
- 2015 – 2021 Bolu Abant Izzet Baysal University Faculty of Medicine
- 2012 – 2015 Bitlis State Hospital (compulsory service)
Memberships
- European Society of Endocrinology (ESE)
- Turkish Society of Endocrinology and Metabolic Diseases
- Turkish Obesity Research Association
Publications
- Can the systemic immune-inflammation index be used as a novel diagnostic tool in the diagnosis of subacute thyroiditis?
Biomarkers in Medicine. 2022;16(10):791-797. DOI: 10.2217/bmm-2022-0095. Keskin Ç , Dilekçi ENA , Üç ZA , Cengiz D, Duran C. - Relationship of glycemic control and diabetes duration with fibromyalgia in patients with type 2 diabetes mellitus
J Bionic Mem 2022; 2(3): 87-95 Dilekçi ENA, Dilekçi E , Keskin C, Cengiz D. - Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients.
Clin Endocrinol (Oxf) 2022 May 31.doi: 10.1111/cen.14787. Yavuz DG, Yazan CD, Hekimsoy, Z, Aydin K, Gokkaya N, Ersoy C, Akalin A, Topaloglu Ö, Aydogan BI, Dilekçi ENA, Üç ZA, Cansu GB, Ozsari L, Iyidir ÖT, - The acromegaly registry of ten different centers in Turkey.
Growth Hormone and IGF research. 2020; 53-54:101322. DOI: 10.1016/j.ghir.2020.101322. Keskin Ç, Demir Ö, Karcı AC, Berker D, Cantürk Z, Yaylalı GF, Topsakal Ş, Ersoy R, Fahri Bayram F, Ertörer ME, Bozkırlı E, Haydardedeoğlu F, Dilekçi E - Evaluation of Platelet Functions in Patients with Hashimoto’s Thyroiditis Versus Healthy Controls: a Cross-Sectional Analysis
Clinical Laboratory, 2019;65:953-958. DOI: 10.7754/Clin.Lab.2018.181009. Gorar S, Alioglu B, Dellal FD, Ademoglu E, Uc ZA, Handan Bekdemir H, Saglam B, Culha C, Aral Y. - Choroidal vascularity index as a predictor for the development of retinopathy in diabetic patients
Journal of Endocrinological Investigation https://doi.org/10.1007/s40618-023-02236-8. C, Dilekci ENA, Ucgul AY, Ucgul YK, Toprak G, Cengiz D. - Is circulating survivin altered in acromegaly?
DOI: 10.5455/medscience.2017.06.8. Ademoglu E, Dilekçi E, Candan Z, Gorar S, Niyazoglu M, Carlioglu A, Yildiz F, Baydar I, Aslan A. - Low levels of circulating platelet factor 4 (PF4, CXCL4) in subclinically hypothyroid autoimmune thyroiditis.
Journal of Endocrinological Investigation, 2016; 39(2): 185-9. DOI: 10.1007/s40618-015-0348-x. Gorar S, Ademoglu E, Carlioglu A, Alioglu B, Bekdemir H, Saglam B, Candan Z, Ucler R, Culha C, Aral Y. - Higher levels of circulating chemerin in obese women with gestational diabetes Mellitus.
Acta Endocrinologica (Bucharest), 2015; 11(1):32-7. DOI: 10.4183/aeb.2015 Ademoglu E, Berberoglu Z, Dellal FD, Ariel MK, Kose A, Candan Z, Bekdemir H, Erdamar H, Culha C, Aral Y. - Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome
Journal of Endocrinological Investigation, 2014; 37(8): 715-9. DOI: 10.1007/s40618-014-0089-2. Ademoglu E, Gorar S, Carlioglu A, Yazici H, Dellal F D, Berberoglu Z, Akdeniz D, Uysal S, Karakurt F.
